Versant Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Versant Capital Management's RVMD Position: Q3 2026 in Review
Versant Capital Management increased its Revolution Medicines (RVMD) stake by 1.2% in Q3 2026, buying an estimated $1.19K and bringing the position to 500 shares worth $103K. The position accounts for 0.01% of the portfolio, ranked #916.
Versant Capital Management first reported a position in RVMD in Q2 2023 and has held it in 10 quarters since. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Versant Capital Management held 500 shares of Revolution Medicines worth $103K as of Q3 2026.
- Versant Capital Management bought 6 Revolution Medicines shares in Q3 2026, an estimated $1.19K.
- Revolution Medicines made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #916 holding.
- Versant Capital Management first reported a position in Revolution Medicines in Q2 2023 and has held it in 10 quarters since.
- 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.